The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways-Reference-Cited by-同舟云学术

The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways

Published:2017-08-24 Issue:42 Volume:8 Page:72835-72846
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Yang Yang¹²,Ji Changwei¹²,Guo Suhan³,Su Xin⁴,Zhao Xiaozhi¹²,Zhang Shiwei¹²,Liu Guangxiang¹²,Qiu Xuefeng¹²,Zhang Qing¹²,Guo Hongqian¹²,Chen Huimei¹⁵

Affiliation:

1. Department of Urology, Drum Tower Hospital Affiliated with Nanjing University School of Medicine, Institute of Urology, Nanjing University, Nanjing 210008, China

2. School of Medicine, Nanjing University, Nanjing 210093, China

3. School of Public Health, Nanjing Medical University, Nanjing 211166, China

4. Center of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China

5. Jiangsu Key Laboratory of Molecular Medicine, Nanjing 210002, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between toenail metals and extracellular MicroRNAs (ex-miRNAs) among the participants of the Normative Aging study (NAS);Environmental Research;2024-11

2. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism;Non-coding RNA Research;2024-06

3. Computational Analysis of Differentially Expressed Circulating MicroRNA and Identification of Key Genes in Prostate Cancer;Indian Journal of Clinical Biochemistry;2024-05-28

4. Role of serum micro-RNA 486-5p in Egyptian cirrhotic hepatitis C patients with hepatocellular carcinoma;The Egyptian Journal of Internal Medicine;2024-02-06

5. Advances in MicroRNA-Mediated Regulation of Cardiomyocyte Injury After Coronary Microembolization;Cardiovascular Innovations and Applications;2024